ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000

In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco

September 24, 1999

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

Carroll Named Deputy Director At Huntsman; Pamer Leads Infectious Disease Service, MSKCC.

September 29, 2000

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979